Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Xavier Cheng‐Hong Tsai"'
Publikováno v:
Tzu-Chi Medical Journal, Vol 36, Iss 2, Pp 127-135 (2024)
Hematopoietic stem cell transplantation (HSCT) can cure malignant and nonmalignant hematological disorders. From 1983 to 2022, Taiwan performed more than 10,000 HSCT transplants. The Taiwan Blood and Marrow Transplantation Registry collects clinical
Externí odkaz:
https://doaj.org/article/a194ce1644f749b6a4a5e5a8b8a45fbd
Autor:
Feng-Ming Tien, Chi-Yuan Yao, Xavier Cheng-Hong Tsai, Min-Yen Lo, Chien-Yuan Chen, Wan-Hsuan Lee, Chien-Chin Lin, Yuan-Yeh Kuo, Yen-Ling Peng, Mei-Hsuan Tseng, Yu-Sin Wu, Ming-Chih Liu, Liang-In Lin, Ming-Kai Chuang, Bor-Sheng Ko, Ming Yao, Jih-Luh Tang, Wen-Chien Chou, Hsin-An Hou, Hwei-Fang Tien
Publikováno v:
Blood Cancer Journal, Vol 14, Iss 1, Pp 1-10 (2024)
Abstract Acute myeloid leukemia (AML) with CEBPA bZIP in-frame mutations (CEBPA bZIP-inf) is classified within the favorable-risk group by the 2022 European LeukemiaNet (ELN-2022). However, heterogeneous clinical outcomes are still observed in these
Externí odkaz:
https://doaj.org/article/a473b9ab2e6e4571988c16d2b5a68bfe
Autor:
Xavier Cheng-Hong Tsai, Hsin-An Hou
Publikováno v:
Journal of the Formosan Medical Association, Vol 123, Iss 1, Pp 137- (2024)
Externí odkaz:
https://doaj.org/article/a5f8f74a4e16466a8aeaab7837e09d57
Autor:
Xavier Cheng-Hong Tsai, Kuo-Jui Sun, Min-Yen Lo, Feng-Ming Tien, Yuan-Yeh Kuo, Mei-Hsuan Tseng, Yen-Ling Peng, Yi-Kuang Chuang, Bor-Sheng Ko, Jih-Luh Tang, Hsun-I Sun, Ming-Chih Liu, Chia-Wen Liu, Chien-Chin Lin, Ming Yao, Wen-Chien Chou, Hsin-An Hou, Hwei-Fang Tien
Publikováno v:
Blood Cancer Journal, Vol 13, Iss 1, Pp 1-11 (2023)
Abstract A set of myelodysplasia-related (MDS-R) gene mutations are incorporated into the 2022 European LeukemiaNet risk classification as adverse genetic factors for acute myeloid leukemia (AML) based on their poor prognostic impact on older patient
Externí odkaz:
https://doaj.org/article/b596d2b3efd1497b8eea73005ee3a8d3
Autor:
Min‐Yen Lo, Xavier Cheng‐Hong Tsai, Chien‐Chin Lin, Feng‐Ming Tien, Yuan‐Yeh Kuo, Wan‐Hsuan Lee, Yen‐Ling Peng, Ming‐Chih Liu, Mei‐Hsuan Tseng, Cheng‐An Hsu, Jui‐Che Chen, Liang‐In Lin, Hsun‐I Sun, Yi‐Kuang Chuang, Bor‐Sheng Ko, Jih‐Luh Tang, Ming Yao, Wen‐Chien Chou, Hsin‐An Hou, Hwei‐Fang Tien
Publikováno v:
American Journal of Hematology. 98:760-769
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9a021f0dac9a6b454eeb007d4a5215a0
https://doi.org/10.1002/ajh.26892
https://doi.org/10.1002/ajh.26892
Autor:
Yuqin Song, Herve Tilly, Shinya Rai, Huilai Zhang, Jie Jin, Hideki Goto, Yasuhito Terui, Ho-Jin Shin, Won Seog S Kim, Junning Cao, Jifeng Feng, Hyeon-Seok Eom, Tae Min Kim, Xavier Cheng-Hong Tsai, Jyh-Pyng Gau, Hideo Koh, Liling Zhang, Yongping Song, Yu Yang, Wei Li, He Huang, Kiyoshi Ando, Jeff P. Sharman, Laurie H Sehn, Lilian Bu, Xin Wang, Yanwen Jiang, Jamie Hirata, Calvin Lee, Jun Zhu, Koji Izutsu
Publikováno v:
Blood.
In the phase 3 POLARIX study (NCT03274492), polatuzumab vedotin combined with rituximab plus cyclophosphamide, doxorubicin and prednisone (Pola-R-CHP) significantly improved progression-free survival (PFS) compared with rituximab plus cyclophosphamid
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7a0b16f96768566881b62fa59cffc8e0
https://doi.org/10.1182/blood.2022017734
https://doi.org/10.1182/blood.2022017734
Autor:
Xavier Cheng-Hong Tsai, Tzu-Ting Chen, Jyh-Pyng Gau, Po-Nan Wang, Yi-Chang Liu, Ming-Yu Lien, Chi-Cheng Li, Ming Yao, Bor-Sheng Ko
Publikováno v:
Cancers; Volume 14; Issue 4; Pages: 1097
Background: The two most noteworthy strategies for haploidentical stem cell transplantation (haplo-HSCT) are posttransplantation cyclophosphamide (PTCy) with or without thymoglobulin (ATG) and granulocyte colony stimulating factor-primed bone marrow
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec300e03748c5f421169bb816cbef1b2
https://doi.org/10.3390/cancers14041097
https://doi.org/10.3390/cancers14041097